Y-mAbs Therapeutics, Inc. (YMAB)
USD 8.78
(-7.87%)
USD 8.78
(-7.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 84.81 Million | 65.26 Million | 34.89 Million | 20.75 Million | - | - |
| Cost of Revenue | 11.41 Million | 7.56 Million | 2.51 Million | 2.2 Million | 166 Thousand | 29 Thousand |
| Gross Profit | 73.4 Million | 57.7 Million | 32.38 Million | 18.54 Million | -166 Thousand | -29 Thousand |
| Operating Expenses | 99.07 Million | 152.51 Million | 147.81 Million | 138.48 Million | 83 Million | 43.23 Million |
| Selling, General and Administrative Expenses | 44.85 Million | 60.93 Million | 54.57 Million | 44.78 Million | 19.51 Million | 8.96 Million |
| Research and Development Expenses | 54.21 Million | 91.57 Million | 93.24 Million | 93.69 Million | 63.49 Million | 34.26 Million |
| Other Expenses | - | - | 62.01 Million | -2.2 Million | - | -44 Thousand |
| Cost and Expenses | 110.49 Million | 160.07 Million | 150.33 Million | 138.48 Million | 83 Million | 43.23 Million |
| Operating Income | -25.67 Million | -94.81 Million | -115.43 Million | -119.93 Million | -83 Million | -43.23 Million |
| Interest Expense | - | 757 Thousand | 1.85 Million | 598 Thousand | 1.97 Million | - |
| Income Tax Expense | 561 Thousand | 757 Thousand | 1.07 Million | -994 Thousand | -2.14 Million | -44 Thousand |
| Earnings before Tax | -20.86 Million | -95.56 Million | -55.27 Million | -119.33 Million | -81.02 Million | -43.27 Million |
| Net Income | -21.42 Million | -96.32 Million | -56.34 Million | -118.34 Million | -78.88 Million | -43.27 Million |
| Earnings Per Share Basic | -0.49 | -2.20 | -1.30 | -2.95 | -2.24 | -1.50 |
| Earnings Per Share Diluted | -0.49 | -2.20 | -1.30 | -2.95 | -2.24 | -1.50 |
| Weighted Average Shares Outstanding | 43.64 Million | 43.7 Million | 43.18 Million | 40.11 Million | 35.18 Million | 28.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.64 Million | 43.7 Million | 43.18 Million | 40.11 Million | 35.18 Million | 28.77 Million |
| Gross Margin | 0.87 | 0.88 | 0.93 | 0.89 | - | - |
| EBIT Margin | -0.30 | -1.45 | -3.31 | -5.67 | - | - |
| Profit Margin | -0.25 | -1.48 | -1.61 | -5.70 | - | - |
| EBITDA | -25.67 Million | -94.72 Million | -54.49 Million | -119.53 Million | -82.83 Million | -43.2 Million |
| Earnings Before Tax Margin | -0.30 | -1.45 | -3.31 | -5.78 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 22.79 Million | 19.93 Million | 23.36 Million | 84.81 Million | 20.45 Million | 20.75 Million |
| Cost of Revenue | 3.01 Million | 2.14 Million | 2.03 Million | 11.41 Million | 2.64 Million | 4.64 Million |
| Gross Profit | 19.78 Million | 17.78 Million | 21.32 Million | 73.4 Million | 17.8 Million | 16.1 Million |
| Operating Expenses | 29.57 Million | 24.69 Million | 24.52 Million | 94.59 Million | 25.55 Million | 23.32 Million |
| Selling, General and Administrative Expenses | 17.23 Million | 11.42 Million | 11.13 Million | - | 10.2 Million | 11.27 Million |
| Research and Development Expenses | 12.34 Million | 13.26 Million | 13.38 Million | - | 15.35 Million | 12.05 Million |
| Other Expenses | -170 Thousand | - | - | - | - | - |
| Cost and Expenses | 32.58 Million | 26.83 Million | 26.56 Million | 106 Million | 28.2 Million | 27.97 Million |
| Operating Income | -9.78 Million | -6.9 Million | -3.19 Million | -21.19 Million | -7.74 Million | -7.22 Million |
| Interest Expense | - | - | 1.29 Million | - | - | - |
| Income Tax Expense | 100 Thousand | 160 Thousand | 195 Thousand | 561 Thousand | 187 Thousand | 179 Thousand |
| Earnings before Tax | -9.14 Million | -6.46 Million | -793 Thousand | -20.86 Million | -7.56 Million | -6.12 Million |
| Net Income | -9.24 Million | -6.62 Million | -988 Thousand | -21.42 Million | -7.74 Million | -6.3 Million |
| Earnings Per Share Basic | -0.21 | -0.15 | -0.02 | - | -0.18 | -0.14 |
| Earnings Per Share Diluted | -0.21 | -0.15 | -0.02 | - | -0.18 | -0.14 |
| Weighted Average Shares Outstanding | 44.02 Million | 43.77 Million | 43.62 Million | 43.64 Million | 43.62 Million | 43.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.02 Million | 43.77 Million | 43.62 Million | 43.64 Million | 43.62 Million | 43.66 Million |
| Gross Margin | 0.87 | 0.89 | 0.91 | 0.87 | 0.87 | 0.78 |
| EBIT Margin | -0.42 | -0.34 | -0.13 | - | -0.38 | -0.35 |
| Profit Margin | -0.41 | -0.33 | -0.04 | -0.25 | -0.38 | -0.30 |
| EBITDA | -9.63 Million | -6.74 Million | -3.03 Million | - | -7.74 Million | -7.22 Million |
| Earnings Before Tax Margin | -0.43 | -0.35 | -0.14 | -0.25 | -0.38 | -0.35 |
OODH
EVLV
001685
8276
4445
AI